Cogent Biosciences, Inc. ( COGT) - Key Metrics
COGT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.56 | -$0.45 | -$0.45 |
| 2026Q1 | $0 | -$0.57 | -$0.51 | -$0.51 |
| 2025Q4 | $0 | -$0.64 | -$0.49 | -$0.50 |
| 2025Q3 | $0 | -$0.58 | -$0.46 | -$0.46 |
| 2025Q2 | $0 | -$0.65 | -$0.48 | -$0.48 |
COGT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -18.61 |
| 2026Q1 | 0% | -16.88 |
| 2025Q4 | 0% | -13.88 |
| 2025Q3 | 0% | -6.19 |
| 2025Q2 | 0% | -2.76 |
COGT
Price: $37.93
52 week price:
Earnings Per Share: -2.18 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 528500
Ebitda: -29.7 millionMarket Capitalization: 6.8 billion